TrialAnnals of the rheumatic diseases2001

Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

P Barrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.